After the pharmaceutical company Pfizer developed a coronavirus vaccine with an initial test efficiency of 90%, Ticketmaster announced a plan to check the vaccine status of concert participants before attending a concert. billboard report.
The proposed system involves the use of Ticketmaster’s digital ticketing application, which will be collected from third-party health information companies (such as IBM’s Digital Health Pass or CLEAR Health Pass) and testing and vaccine distribution providers (such as Labcorp or CVS Minute Clinic) information. The goal is to ensure safety by verifying the fan’s vaccination status or whether it has been tested negative for COVID-19 within 24 to 72 hours.
Ticketmaster has also developed digital ticketing related to the identity of ticket purchasers, and a SmartEvent system that can help strengthen social distancing, delayed entry and contact tracking. Event organizers will be able to set up specific prevention programs, including sanitation facilities, obey masks and stay away from society.
The specific timetable for the widespread availability of the vaccine is not yet clear. According to reports, the timetable is free for the American public. When commented, Ticketmaster President Mark Yovich told Pitchfork:
Pitchfork also contacted representatives of Live Nation Entertainment to inquire about potential costs related to Ticketmaster’s COVID-19 vaccine status policy.
German scientists recently released the results of their experiments to spread the coronavirus at a concert. This study has not been peer-reviewed and found that as long as concert participants follow hygienic procedures and the venue is well ventilated and the capacity is limited, the risk of spreading coronavirus at indoor concerts is “low to very low.”